Indian Ras Exporters: Complete Supplier Ranking with Market Share — 1156 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ras supplier from India?

CIPLA LIMITED is the largest ras exporter from India with a 14.9% market share and export value of $45.9M.

Q: How many ras suppliers are there in India?

There are 1156 active ras exporters in India, collectively shipping $307.2M worth of ras across 15,000 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ras suppliers from India?

The top 5 ras suppliers from India — CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, BIOCON BIOLOGICS INDIA LIMITED — together control 53.6% of total ras export value from India.

Suresh Sormare

Ras

India Pharmaceutical Trade Intelligence

$307.2M1,156 Suppliers176 CountriesHS 30049099

ExportsIndia → UNITED STATES29.3%India → SINGAPORE13.2%

#1 Supplier: CIPLA LIMITED

Ras Suppliers from India (2026) — 1156 Exporters, $307.2M Market | TransData Nexus | TransData Nexus

Who Exports Ras from India — 1156 Suppliers Behind a $307.2M Market

India's ras export market is supplied by 1156 active exporters who collectively shipped $307.2M across 15,000 shipments. CIPLA LIMITED leads with a 14.9% market share, followed by INTAS PHARMACEUTICALS LIMITED and MYLAN LABORATORIES LIMITED. The top 5 suppliers together control 53.6% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Ras Suppliers & Exporters — 1156 manufacturers, $307.2M export market, top destinations and formulations — Ras supplier data — 1156 exporters · $307.2M market · 15,000 shipmentsTransData Nexus · Indian Customs Data

Top Ras Exporters from India — Ranked by Export Value

CIPLA LIMITED is the leading ras exporter from India, holding a 14.9% share of the $307.2M market across 15,000 shipments from 1156 exporters. The top 5 suppliers — CIPLA LIMITED, INTAS PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, BIOCON BIOLOGICS INDIA LIMITED — collectively control 53.6% of total export value, indicating a moderately concentrated market. Individual shares are: CIPLA LIMITED (14.9%), INTAS PHARMACEUTICALS LIMITED (13.4%), MYLAN LABORATORIES LIMITED (13.1%), MSN LABORATORIES PRIVATE LIMITED (7.3%), BIOCON BIOLOGICS INDIA LIMITED (4.9%).

Top Ras Exporters from India

Ranked by export value · 1156 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Ras Exporters from India — Ranked by Export Value. 1156 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	CIPLA LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Ras exporters

Certification and compliance status for top Ras suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Approved	Yes (as of September	Yes	Multiple	CIPLA LIMITED holds FDA approvals, WHO-GMP certification (September 2025), and E
INTAS PHARMACEUTICALS LIMITED	Warning Letter (November	Yes (as of September	Yes	Multiple	Received FDA warning letter in November 2023 for data integrity issues at Ahmeda
MYLAN LABORATORIES LIMITED	Approved	Yes (as of September	Yes	Multiple	MYLAN LABORATORIES LIMITED holds FDA approvals, WHO-GMP certification (September
MSN LABORATORIES PRIVATE LIMITED	Approved	Yes (as of September	Yes	Multiple	MSN LABORATORIES PRIVATE LIMITED holds FDA approvals, WHO-GMP certification (Sep
BIOCON BIOLOGICS INDIA LIMITED	Approved	Yes (as of September	Yes	Multiple	BIOCON BIOLOGICS INDIA LIMITED holds FDA approvals, WHO-GMP certification (Septe
ALKEM LABORATORIES LIMITED	Approved	Yes (as of September	Yes	Multiple	ALKEM LABORATORIES LIMITED holds FDA approvals, WHO-GMP certification (September
DR. REDDY'S LABORATORIES LTD	Approved	Yes (as of September	Yes	Multiple	DR. REDDY'S LABORATORIES LTD holds FDA approvals, WHO-GMP certification (Septemb
USV PRIVATE LIMITED	Approved	Yes (as of September	Yes	Multiple	USV PRIVATE LIMITED holds FDA approvals, WHO-GMP certification (September 2025),
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes (as of September	Yes	Multiple	SUN PHARMACEUTICAL INDUSTRIES LIMITED holds FDA approvals, WHO-GMP certification

TransData Nexus reviewed the regulatory standing of 9 leading Ras exporters from India. 8 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Ras sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. The city hosts over 200 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment and Manufacturing Zone (NIMZ), aims to further bolster this sector by providing a self-sustained ecosystem for pharmaceutical manufacturing and research.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations. Gujarat accounts for 33% of India's drug manufacturing and 28% of drug exports, with Ahmedabad and Vadodara being central to this output. The region is home to numerous pharmaceutical companies, including Alembic Pharmaceuticals, which specializes in formulations for therapeutic areas such as cardiology and infectious diseases.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical industry. Mumbai's strategic location and well-developed port infrastructure facilitate efficient international distribution of pharmaceutical products. The region hosts several leading pharmaceutical companies, including Sun Pharmaceutical Industries Limited and Cipla Limited, which are among the top exporters of "Ras."

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Ras exporters from India

April 2024

M&A

CIPLA LIMITED — Cipla acquires Ivia Beaute's personal care brands for ₹130 crore

Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd, including brands like Astaberry and Ikin, for ₹130 crore, with an additional ₹110 crore contingent on milestones. This acquisition aims to expand Cipla's consumer health portfolio into skincare and personal hygiene products. IMPACT: This diversification may lead to a strategic shift in focus, potentially affecting Cipla's emphasis on Ras exports.

Impact: This diversification may lead to a strategic shift in focus, potentially affecting Cipla's emphasis on Ras exports.

November 2022

M&A

BIOCON BIOLOGICS INDIA LIMITED — Biocon Biologics acquires Viatris' biosimilars business for $3 billion

Biocon Biologics completed the acquisition of Viatris' biosimilars portfolio for $3 billion, enhancing its global biosimilars presence. IMPACT: This acquisition is expected to strengthen Biocon's biosimilars offerings, potentially increasing its Ras exports.

Impact: This acquisition is expected to strengthen Biocon's biosimilars offerings, potentially increasing its Ras exports.

Common Questions — Ras Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which ras supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, CIPLA LIMITED leads with 166 recorded shipments worth $45.9M. INTAS PHARMACEUTICALS LIMITED (731 shipments) and MYLAN LABORATORIES LIMITED (402 shipments) are also established high-volume exporters.

Q How many ras manufacturers are there in India?

India has 1156 active ras exporters with a combined export market of $307.2M across 15,000 shipments to 176 countries. The top 5 suppliers hold 53.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ras

Ras